These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 39008499

  • 1. Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
    Nasr MA, Aldous A, Daniels J, Joy C, Capozzi E, Yang M, Moriarty P, Emmanuel-Baker V, Malcolm S, Green SJ, Gomez-Lobo V, Ghosh M.
    PLoS One; 2024; 19(7):e0306237. PubMed ID: 39008499
    [Abstract] [Full Text] [Related]

  • 2. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB, Tang JH, Davis NL, Kourtis AP, Chinula L, Msika A, Tegha G, Hosseinipour MC, Nelson JAE, Hobbs MM, Gajer P, Ravel J, De Paris K.
    mSphere; 2023 Feb 21; 8(1):e0058522. PubMed ID: 36622252
    [Abstract] [Full Text] [Related]

  • 3. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE, Tharp GK, Patel NB, Zhao C, Payne TL, Dietz Ostergaard S, Butler K, Ellis S, Johnson RL, Kersh EN, McNicholl JM, Vishwanathan SA.
    Am J Reprod Immunol; 2018 Oct 21; 80(4):e13029. PubMed ID: 30076667
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF.
    Contraception; 2013 Oct 21; 88(4):503-8. PubMed ID: 23582238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.
    mBio; 2015 Sep 01; 6(5):e00221-15. PubMed ID: 26330510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.
    Yang L, Hao Y, Hu J, Kelly D, Li H, Brown S, Tasker C, Roche NE, Chang TL, Pei Z.
    Emerg Microbes Infect; 2019 Sep 01; 8(1):197-210. PubMed ID: 30866773
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
    Achilles SL, Meyn LA, Mhlanga FG, Matubu AT, Stoner KA, Beamer MA, Chirenje ZM, Hillier SL.
    Am J Reprod Immunol; 2020 Sep 01; 84(3):e13287. PubMed ID: 32533883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
    Morrison CS, Hofmeyr GJ, Thomas KK, Rees H, Philip N, Palanee-Phillips T, Nanda K, Nair G, Onono M, Mastro TD, Lind M, Heffron R, Edward V, Deese J, Beksinska M, Beesham I, Stringer JSA, Baeten JM, Ahmed K, ECHO Trial Team.
    AIDS Res Hum Retroviruses; 2020 Aug 01; 36(8):632-640. PubMed ID: 32394723
    [Abstract] [Full Text] [Related]

  • 16. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS, Fichorova R, Chen PL, Kwok C, Deese J, Yamamoto H, Anderson S, Chipato T, Salata R, Doncel GF.
    AIDS Res Hum Retroviruses; 2018 Oct 01; 34(10):889-899. PubMed ID: 30047279
    [Abstract] [Full Text] [Related]

  • 17. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
    Singata-Madliki M, Lawrie TA, Balakrishna Y, d'Hellencourt FC, Hofmeyr GJ.
    Reprod Health; 2021 Sep 29; 18(1):192. PubMed ID: 34587971
    [Abstract] [Full Text] [Related]

  • 18. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
    Quispe Calla NE, Vicetti Miguel RD, Boyaka PN, Hall-Stoodley L, Kaur B, Trout W, Pavelko SD, Cherpes TL.
    Mucosal Immunol; 2016 Nov 29; 9(6):1571-1583. PubMed ID: 27007679
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
    Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C.
    BMC Womens Health; 2024 Mar 08; 24(1):167. PubMed ID: 38459552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.